Reference
Rolli FR, et al. Economic evaluation of Zepatier for the management of HCV in the Italian scenario. European Journal of Health Economics : 25 Apr 2018. Available from: URL: https://doi.org/10.1007/s10198-018-0980-4
Rights and permissions
About this article
Cite this article
Elbasvir/grazoprevir cost effective for hepatitis C in Italy. PharmacoEcon Outcomes News 803, 13 (2018). https://doi.org/10.1007/s40274-018-4940-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4940-0